Delivery Order SPE2DX22D0049-SPE2D826FA0PG

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,379.98 by the Defense Logistics Agency's Medical Supply Chain on October 20, 2025. This firm fixed-price delivery order, which is expected to be completed by October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, consistent with AmerisourceBergen's track record of competitively winning federal pharmaceutical procurement contracts.

As a prime vendor on the DLA Troop Support Medical contract, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates capability across multiple therapeutic domains, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order represents one of numerous transactions executed under the broader pharmaceutical prime vendor arrangement that enables flexible fulfillment of critical medical supply needs across global military healthcare operations.